µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º U H
`=
sF f@>
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ `BF +)fs
r m\]
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) x7> '
1
<U$x')W
1. ICAM-1 !w{4FE74
q\/ph(HF
2. interleukin 12(IL-12) Qw}uB$S>
=g
UOHH
3. tumor infiltrating lymphocyte Ja"?Pb
U]ynnw4
4. TCR/CD3 complex ~5q1zr)E
F}wy
7s2i
5. hematopoietin receptor family Y;-$w|&P>
,` 6O{Z~
6. individual idiotype(IdI) "m4
._4U
j4k\5~yzS
7. integrin u0zF::
O`K2mt\%
8. colony-stimulatory factor (CSF) z{`K_s%5
X|y(B%:
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© {bHUZen
{7'Wi$^F
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? +fS<YT
\Kr8k`f
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ i'V("
l0 =[MXM4
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠ%
bfe_k(
YLJ^R$pi
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ !6!Gx:
xP4}LL9)
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) ^G|*=~_
5EU~T.4C<
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ aD]!
eP/)
i/j53towe
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) Y<L35
?
qv& Bai[
3. immunoglobulin superfamily (IgSF) G/*;h,NbNr
&AN1x
cx\
4. selectin &1(- 8z*
_Jy7` 4B.
5. anti-idiotypic antibody (¦ÁId) 1U%
/~
_f'v
>"K
6. major histocompatibility complex(MHC) />Q}0Hg
@-}*cQ4u?
7. immunotolerance 6<EGH*GQ$
AtewC
Yo
8. biological reponse modifier(BRM) NMe{1RM
<+k"3r{y"
9. immune reponse gene (Ir gene) XeX"IhgS>E
3/>
7b(
10. reshaped antibody (or reconstituted antibody) MjU|XQS:
d2V X\
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© [% C,&h5
H T|DT
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ kk%3 2(By
_Z23l
F9
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? _]-4d_&3(
nq)F$@
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ VG);om7`PD
D7;9D*o\
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? qOwql(vX
X H-_tv
B
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ x@t?7 o\&
@1MnJP
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? .UG`pRC
xG9Sk
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ A*EOn1hN
wDJ`#"5p{
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ !sb r!Qt
uu9M}]mDl
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? ffZ~r%25{
s6!6Oqh
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ vADiW~^Q^
Y;"k5+ q
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: MUO<o
M|WBJ'#x0
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: CKYg!\g(:
fw%`[(hK
̉񧄤 p
+VU:%.t
<+`%=r)4
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© KdkA@>L!;
c3$T3Lu1
1. CD8 'nmA!s
eb62(:=N6
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) (_T{Z>C/J
*'%V}R[>
3. immunoglobulin fold(Ig fold) ]&cnc8tC
. %
RM8
4. cadherin (Ca-dependent cell adhesion moleculers) i0vm0
0oT
p4`1^}f&Ie
5. idiotype-anti-idiotypic antibody immune network theory B,%Vy!o
"mlQ z4D)5
6. HLA class II antigen Harg<l
{/'T:n#
7. complementarity-determining region (CDR) +P/kfY"
g^ AQBF
8. perforin(or pore-forming protein ,PFP) T$4{fhV
\
'xwCeZcg
9. high affinity IL-2 receptor 7]ieBUfS
(eHyas %X
10. artificial active immunization /:{%X(8
Y
G+|r
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© vQAFg G
}F`|_8L*v)
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠe#"h@kZP
{ e|qQ4~h
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 A1WUK=P
9T,/R1N8
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ 3DU1c?M:
Fn4v/)*H
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ 8|u
4xf<
Up9{aX
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ %fS9F^AK
zWsr|= [
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? +y7z>Fwl
lC i{v.
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ 20:F$d
mxc)Wm<4
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ sD|l}f
Xn7G2Yp
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ^X#y'odtbS
-<iP$,bq72
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ
c-Lz luWi
L/3A g*
]
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© "wUIsuG/p
m[DQ;`Y
1. immunoglobulin gene rearrangement 3Ax'v|&Hg
g \mE
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) [Nyt0l "z
kZ]H[\Fs
3. flow cytometry(FCM) m</m9h8
#]#9Xq
4. carrier effect Q>niJ'7WF
AtT7~cVe
5. positive selection of T lymphocytes in thymus Qg> NJ\*Q
sp K8^sh
6. mouse TH1(Th1) and TH2(Th2) subsets iL/c^(1
| /.J{=E0K
7. perforin (pore-forming protein ,PFP) 2"/MM2s
8}/DD^M
8. ADCC(antibody-dependent cell-mediated cytotoxicity) W4$o\yA]
,67Q!/O
9. SH-2(src-homology region 2) >e]g T
_&KqmQ8$7
10. Ab2¦Â (internal image) ]8G 'R-8}
Mz+I
YP`L
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© \Ne`9k
q^X7x_
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? t}t(fJHY`
aq,1'~8XR
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? BR|!ya+_2
nz 10/nw
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦ÓᣠW'G|sk
j?T'N:Qd
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ 5(;Y&?k
p.8 bX
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦Óᣠv>X!/if<y
e02Hf{eOfw
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) 4KPnV+h"b
e=]SIR()`
ÃâÒßѧרҵ£º tFU4%c7V
EKc<|e,F
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ If'q8G3]-
?;~!C2Zs
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? C T~6T&'
/R&`]9].s
´«È¾²¡Ñ§×¨Òµ£º j26i+Z
\((MoQ9Qk
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ FDoPW~+[
0kJ8H!~u
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ lHiWzt
u
Y S3~sA
Ïû»¯×¨Òµ£º -TD\?Q
k?=1q[RQH
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ VQIvu)I
fW= N
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ?
O_ _s~
(KI9j7
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ `2>p#`
`wa;@p+j8
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© XPhP1 ^>\
Kebr>t8^
1. Fas(CD95)/FasL +~n:*\
tE%g)hL-
2. common chain of cytokine receptor
$9%F1:u
7
U7!'xU
3 . TCR/CD3 complex re*Zs}(N\
9!Av sC9
4. negaive selection of thymocytes aOvqk ^
:2lpl%/
5. artificial active immune 1$RJzHS
eipg,EI
6. anti-idiotypic Cl'$*h
*I :c@iCNJ
7. IgSF qu^g~"s
ZtZ3I?%U3
8. Integrin |ufL s
4AN8Sx(
9. chemokine LZ wCe$1
mr7Oi `dE
10. B7/CD28 XQ~Xls%]
m 3UK`~ji
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© uZ8-?
u7mPp3ZYK
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ nA0%M1a
mrr]{K
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ ='jT
5Mg
Mf14> `<`
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ LxIGPC~
<O7!(
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ 6=n|Ha
"dP-e
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ EMP|I^
4Q0ZY(2 EO
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ 7;|"1H:cmw
,=\.L_'
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 4GP?t4][
H?O5 "4a
1. B7/CD28 XfE0P(sE
PwW$=M{\.
2. Th1 subset K ,NmDc^
QL
8C
!&=
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© el`?:dY H
K@*+;6y@
4. antibody affinity maturation @Dfg6<0
0?$|F0U"J
5. AP-1 vD@|]@gq
7zCJ3p
6. single chain variable fragment£¨ScFv£© nBp6uNK[
~<!j]@.
7. NK cell receptor tkZUjQIX
<[\I`kzq
8. Zinkernagel-Doherty phenomenon 1SztN3'q
#M|lBYdW}
9. Ig fold V K6D
D(ItNMcKu
10. CD40/CD40L H2%Qu<Kg2
7:olStK
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© 'UhHcMh:
;+XrCy!.)L
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ cy.r/Z}
s>o#Ob@4'
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ +ZNOvcsV
]O@iT= *3
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ }},0#Ap
F8Ety^9>9
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ z.8 nYL5^}
iOg4(SPci
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ Zpg;hj5_
Qwpni^D8j
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ )9"^ D
6}-No
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ ,:PMS8pS
P6.PjK!Ar
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© I`{*QU
$h
pUI
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© jzV"( p!
r{v3XD/
1.Co-stimulators (or co-stimulating molecules) 3eE=>E
4,
eR \duZ!`
2.NK-kB rQ{|0+l
?pZU'5le`
3.Immunoglobulin superfamily )iw-l~y;
~\JB)ca.
4.antigen-presenting cell (APC) J[:#(c&c!1
0RA#Y(IR
5.death domain L@GICW~
n#x_da-m]
6.CCR and CXCR Pv5S k8
g)czJ=T2
7.Lectin (or mitogen) dP_QkO
9<?w9D.1
8.Clusters of differentiation, CD) c
qCNk
b\ED<'
9.B7 family O80Z7
&D M3/^70
10.Cytotoxic T lymphocyte, CTL) 5
NYS@76o7
n~6$CQ5dF(
11.IL-15 and IL-15 receptor (IL-15R) a?+C]u?_D
4A@HR
12.MHC restriction Pr}
l
y
kEq~M10
13.Affinity-chromatography &6CDIxH{
YaS!YrpI
14.Cyctosprin A, CsA ]\fHc"/
]~]TZb
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) wqDf\k}'v
;U4O` pZ
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 1sg:8AA
{D8opepO)
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 #@HlnF}T
/95z1e
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ ).jQ+XE'>
q'S[TFMNE
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ /F.<Gz;w
l\L71|3" g
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© tLKf]5}f
Me z&@{
ÃâÒßѧרҵ£º C1f$^N
rEp\ld
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ O\Y*s
bJPKe]spJ=
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ 0B1nk!F
|(tl
a_LE
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ +vJ}'uR3P
F\&wFA'J
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) S^~"#
F}mt
*UcMG
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) :-59~8&
nT:<_'!
1. ADCC(antibody dependent cell-mediated cytotoxicity) eptw)S-j
Y/UvNb<lK
2. »·æß¾úËØ(cyclosporin) y)|d`qC\
>P(.yQ8&kL
3. KIR(killer cell inhibitory receptor) vt"bB
r-S%gG}~E
4. HLDA(human leucocyte differentiation antigen) E
dc3YSg%;
)/!HI0TU
5. Interleukin 18(IL-18) ,e 7
~G
C+!=C{@7di
6. ÕûºÏËØ(integrin) gZ>&cju
rvhMu}.
7. Fas/FasL {7X9P<<L7
Zd)LVc[
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) 6&i])iH
'"%hX&]5
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) fZap\
.+8#&Uy
10. Th1/Th2 g|^U?|;p
lM#/F\
11. »ùÒòÒßÃç(DNAÒßÃç) yN[i6oe
(O:&RAkk7
12. chemokines and chemokine receptor DcRoW
@QpL*F
13. ÃâÒßÄÍÊÜ 0"\js:-$
;)f,A)(Z
14. ¹²´Ì¼¤·Ö×Ó 3# 0N
d"/0
aY,'^S
15. ËÀÍö½á¹¹Óò(death domain) R SWw4}
Cvt/ot-J?
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) b,ZBol|X
1,P2}mYv
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? \,nhGh
{v d
+cE
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óᣠ-:!T@rV,d
H%>cpwa[7
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î @v6{U?
XGnC8Be{4
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ SrdCLT8
Cw.DLg
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå >6(e6/C-9
&oVZ2.O#(
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ ^D
{v L
sU^K5oo
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) Y$hLsM\%
,I f9w$(z
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ We"\nOP
B]#iZ,Tp
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ Ao9=TC'v$'
FePWr7Ze
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£